Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A novel tubulin inhibitor, 6h, suppresses tumor-associated angiogenesis and shows potent antitumor activity against non–small cell lung cancers
Zi Liu, Liancheng Huang, Tianhao Zhou, et al.
Journal of Biological Chemistry (2022) Vol. 298, Iss. 7, pp. 102063-102063
Open Access | Times Cited: 10

Showing 10 citing articles:

Recent updates on 1,2,3-triazole-containing hybrids with in vivo therapeutic potential against cancers: A mini-review
Shijia Zhao, Jie Liu, Zaosheng Lv, et al.
European Journal of Medicinal Chemistry (2023) Vol. 251, pp. 115254-115254
Closed Access | Times Cited: 44
The microbiome in the pathogenesis of lung cancer
Sainan Miao, Huan Qiu
Apmis (2023) Vol. 132, Iss. 2, pp. 68-80
Closed Access | Times Cited: 5
Novel Tetrazole Derivatives Targeting Tubulin Endowed with Antiproliferative Activity against Glioblastoma Cells
Laura Gallego‐Yerga, Andrea Jazmín Chiliquinga, Rafael Peláez
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 11093-11093
Open Access | Times Cited: 3
ZYY-B-2, a novel ALK inhibitor, overcomes resistance to ceritinib by inhibiting P-gp function and induces apoptosis through mitochondrial pathway in ceritinib-resistant H2228 cells
Ying Gao, Tong Liu, Jin‐Gang Liu, et al.
Chemico-Biological Interactions (2023) Vol. 379, pp. 110516-110516
Closed Access | Times Cited: 2
Synthesis of Competitive and Noncompetitive Inhibitors of Alpha‐Glucosidase and Anticancer Agents
Usman Ghani, Saeed Ali Syed, Sarah Aljunidel, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 5
Closed Access
Biological activity of a stable 6-aryl-2-benzoyl-pyridine colchicine-binding site inhibitor, 60c, in metastatic, triple-negative breast cancer
Damilola Oluwalana, Kelli L. Adeleye, Raisa I. Krutilina, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Biological activity of a stable 6-aryl-2-benzoyl-pyridine colchicine-binding site inhibitor, 60c, in metastatic, triple-negative breast cancer
Damilola Oluwalana, Kelli L. Adeleye, Raisa I. Krutilina, et al.
Cancer Letters (2024) Vol. 597, pp. 217011-217011
Open Access
Novel Antimitotic Agent SP-1-39 Inhibits Head and Neck Squamous Cell Carcinoma
K.L. Adeleye, A.R. Li, Yang Xie, et al.
Journal of Dental Research (2024) Vol. 103, Iss. 9, pp. 926-936
Closed Access
Microtubule dynamics in cancer metastasis: Harnessing the underappreciated potential for therapeutic interventions
Snehal Mangaonkar, Sangeeta Nath, Biswa Prasun Chatterji
Pharmacology & Therapeutics (2024) Vol. 263, pp. 108726-108726
Open Access
Design, synthesis and evaluation of dihydro-1 H -indene derivatives as novel tubulin polymerisation inhibitors with anti-angiogenic and antitumor potency
Shengtao Xu, Yijun Sun, Peng Wang, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 1
Page 1

Scroll to top